Mohammad Mashreghi

Mr. Mohammad Mashreghi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZSZahra Seyedi
Zahra Seyedi
MAMohammad Sadegh Amiri
Mohammad Sadegh Amiri
VMVahideh Mohammadzadeh
Vahideh Mohammadzadeh
AHAlireza Hashemzadeh
Alireza Hashemzadeh
AHAliakbar Haddad-Mashadrizeh
Aliakbar Haddad-Mashadrizeh
MYMohammad Ehsan Taghavizadeh Yazdi
Mohammad Ehsan Taghavizadeh Yazdi
Among scaffolds used in tissue engineering, natural biomaterials such as plant-based materials show a crucial role in cellular function due to their biocompatibility and chemical indicators. Because of environmentally friendly behavior and safety, green methods are so important in designing scaffolds. A key bioactive flavonoid of the Epimedium plant, Icariin (ICRN), has a broad range of applications in improving scaffolds as a constant and non-immunogenic material, and in stimulating the cell growth, differentiation of chondrocytes as well as differentiation of embryonic stem cells towards cardiomyocytes. Moreover, fusion of ICRN into the hydrogel scaffolds or chemical crosslinking can enhance the secretion of the collagen matrix and proteoglycan in bone and cartilage tissue engineering. To scrutinize, in various types of cancer cells, ICRN plays a decisive role through increasing cytochrome c secretion, Bax/Bcl2 ratio, poly (ADP-ribose) polymerase as well as caspase stimulations. Surprisingly, ICRN can induce apoptosis, reduce viability and inhibit proliferation of cancer cells, and repress tumorigenesis as well as metastasis. Moreover, cancer cells no longer grow by halting the cell cycle at two checkpoints, G0/G1 and G2/M, through the inhibition of NF-κB by ICRN. Besides, improving nephrotoxicity occurring due to cisplatin and inhibiting multidrug resistance are the other applications of this biomaterial.

20 June 2023 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MMMohammad Mashreghi
Mohammad Mashreghi
BGBabak Daneshvar Ghorbani
Babak Daneshvar Ghorbani
MKMd. Saifuddin Khalid
Md. Saifuddin Khalid
ALAynaz Lotfata
Aynaz Lotfata
HTHamed Tabesh
Hamed Tabesh
Background: Implementing workplace preventive interventions reduces occupational accidents and injuries, as well as the negative consequences of those accidents and injuries. Online occupational safety and health training is one of the most effective preventive interventions. This study aims to present current knowledge on e-training interventions, make recommendations on the flexibility, accessibility, and cost-effectiveness of online training, and identify research gaps and obstacles. Method: All studies that addressed occupational safety and health e-training interventions designed to address worker injuries, accidents, and diseases were chosen from PubMed and Scopus until 2021. Two independent reviewers conducted the screening process for titles, abstracts, and full texts, and disagreements on the inclusion or exclusion of an article were resolved by consensus and, if necessary, by a third reviewer. The included articles were analyzed and synthesized using the constant comparative analysis method. Result: The search identified 7,497 articles and 7,325 unique records. Following the title, abstract, and full-text screening, 25 studies met the review criteria. Of the 25 studies, 23 were conducted in developed and two in developing countries. The interventions were carried out on either the mobile platform, the website platform, or both. The study designs and the number of outcomes of the interventions varied significantly (multi-outcomes vs. single-outcome). Obesity, hypertension, neck/shoulder pain, office ergonomics issues, sedentary behaviors, heart disease, physical inactivity, dairy farm injuries, nutrition, respiratory problems, and diabetes were all addressed in the articles. Conclusion: According to the findings of this literature study, e-trainings can significantly improve occupational safety and health. E-training is adaptable, affordable, and can increase workers’ knowledge and abilities, resulting in fewer workplace injuries and accidents. Furthermore, e-training platforms can assist businesses in tracking employee development and ensuring that training needs are completed. Overall, this analysis reveals that e-training has enormous promise in the field of occupational safety and health for both businesses and employees.

Verified
Journal Article
Open access
PDF file
SMSeyed Mousa Mousavi-Kouhi
Seyed Mousa Mousavi-Kouhi
AKAbdollah Beyk Khormizi
Abdollah Beyk Khormizi
MAMohammad Sadegh Amiri
Mohammad Sadegh Amiri
MMMohammad Mashreghi
Mohammad Mashreghi
AHAlireza Hashemzadeh
Alireza Hashemzadeh
MYMohammad Ehsan Taghavizadeh Yazdi
Mohammad Ehsan Taghavizadeh Yazdi
In this study, a novel method using Ferula gummosa gums as a capping agent was used to synthesize the nanoceria for the first time. The method was economical and performed at room temperature. Furthermore, it was coated with gold (Au/nanoceria) and fully characterized using X-ray powder diffraction (XRD), field emission scanning electron microscopy with energy-dispersive X-ray spectroscopy (FESEM-EDX), Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), and zeta potential (ζ potential). The crystallite size obtained from the results was 28.09 nm for Au/nanoceria. The energy-dispersive X-ray spectroscopy (EDX) analysis of Au/nanoceria revealed the compositional constituents of the product, which display the purity of the Au/nanoceria. The cell toxicity properties of the non-doped and Au-coated nanoceria were identified by a MTT analysis on a breast cancer cell line (MCF7). Additionally, human foreskin fibroblast cells (HFF) were used as a normal cell line. The cytotoxicity results indicated that the toxicological effect of Au/nanoceria on cancer cells was significant while having little toxic effect on normal cells. The toxicity effect of nanoceria clearly shows the dependence on dose and time, so, with increasing the dose of Au/nanoceria, the death of cancer cells also increases.

8 March 2021 in Journal of Drug Targeting
Verified
Journal Article
Closed access
MMMohammad Mashreghi
Mohammad Mashreghi
MMMahdi Faal Maleki
Mahdi Faal Maleki
MKMaryam Karimi
Maryam Karimi
FKFatemeh Kalalinia
Fatemeh Kalalinia
ABAli Badiee
Ali Badiee
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
The aim of this study was to surface-functionalize PEGylated liposomal doxorubicin (PLD) using anti-p32 CGKRK peptide to evaluate its anti-angiogenic and anti-tumour activities. CGKRK was conjugated to DSPE-mPEG2000-maleimide and post-inserted into PLD at 25, 50, 100, 200 and 400 peptides per each liposome and characterised for their size, zeta potential, drug loading, release properties; and cell binding, cell uptake and cytotoxicity on three C26, 4T1 and human umbilical vein endothelial cell (HUVEC) cell lines. The in vitro results indicated the better efficiency of the PLD-100 (PLD with 100 CGKRK) formulation on 4T1 and HUVEC cell lines. The results of anti-tube formation and spheroid assay indicated the efficiencies of the PLD-100 formulation compared with Caelyx® in vitro. The in vivo studies indicated the higher tumour accumulation of PLD-100 formulation in comparison with Caelyx® which also implied the higher survival rates in mice treated with PLD-100 formulation. Histological evaluations demonstrated that PLD-100 had no side-effects on major organs. In conclusion, the results of this study indicated that PLD-CGKRK- could efficiently target endothelial and tumour parenchymal cells which enhance the therapeutic efficacy of PLD and merits further investigation.

1 February 2013 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MMMohammad Mashreghi
Mohammad Mashreghi
MBMahere Rezazade Bazaz
Mahere Rezazade Bazaz
NSNasser Mahdavi Shahri
Nasser Mahdavi Shahri
AAAhmad Asoodeh
Ahmad Asoodeh
MMMansour Mashreghi
Mansour Mashreghi
SGShiva Golmohammadzadeh
Shiva Golmohammadzadeh

29 January 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SSSusan Sarhadi
Susan Sarhadi
SMSeyedeh Alia Moosavian
Seyedeh Alia Moosavian
MMMohammad Mashreghi
Mohammad Mashreghi
NRNiloufar Rahiman
Niloufar Rahiman
SGShiva Golmohamadzadeh
Shiva Golmohamadzadeh
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari